Evaluation of muscle protein mass in children with solid tumors by muscle thickness measurement with ultrasonography, as compared with anthropometric methods and visceral protein concentrations.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 9683391)

Published in Eur J Clin Nutr on June 01, 1998

Authors

M Taskinen1, U M Saarinen-Pihkala

Author Affiliations

1: Hospital for Children and Adolescents, University of Helsinki, Finland.

Articles by these authors

Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet (2000) 3.39

Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Nordic Society of Pediatric Haematology and Oncology (NOPHO). Leukemia (2000) 1.56

Intensified treatment of acute childhood lymphoblastic leukaemia has improved prognosis, especially in non-high-risk patients: the Nordic experience of 2648 patients diagnosed between 1981 and 1996. Nordic Society of Paediatric Haematology and Oncology (NOPHO) Acta Paediatr (1998) 1.53

Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant (2000) 1.17

Long-term adverse effects on dentition in children with poor-risk neuroblastoma treated with high-dose chemotherapy and autologous stem cell transplantation with or without total body irradiation. Bone Marrow Transplant (2002) 0.98

AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia. Haematologica (2000) 0.90

Hematopoietic stem cell transplantation in infantile neuronal ceroid lipofuscinosis. Neurology (2001) 0.90

Circulating dendritic cell subset levels after allogeneic stem cell transplantation in children correlate with time post transplant and severity of acute graft-versus-host disease. Bone Marrow Transplant (2005) 0.88

Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Bone Marrow Transplant (1999) 0.88

Suboptimal long-term physical performance in children and young adults after pediatric allo-SCT. Bone Marrow Transplant (2009) 0.86

Pain medication during terminal care of children with cancer. J Pain Symptom Manage (1998) 0.86

Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries. Bone Marrow Transplant (1999) 0.85

Dendritic cell subsets in childhood and in children with cancer: relation to age and disease prognosis. Clin Exp Immunol (2004) 0.85

Integrated analysis of gene copy number, copy neutral LOH, and microRNA profiles in adult acute lymphoblastic leukemia. Cytogenet Genome Res (2012) 0.85

Autopsy in children with cancer who die while in terminal care. Med Pediatr Oncol (1998) 0.83

Higher angiopoietin-2 and VEGF levels predict shorter EFS and increased non-relapse mortality after pediatric hematopoietic SCT. Bone Marrow Transplant (2012) 0.82

Coping of parents and siblings with the death of a child with cancer: death after terminal care compared with death during active anticancer therapy. Acta Paediatr (2000) 0.82

Successful liver transplantation after induction chemotherapy in children with inoperable, multifocal primary hepatic malignancy. Transplantation (1999) 0.82

Ovarian function after allogeneic hematopoietic stem cell transplantation in childhood and adolescence. Eur J Endocrinol (2013) 0.80

Expression of myeloid-specific genes in childhood acute lymphoblastic leukemia - a cDNA array study. Leukemia (2002) 0.80

Naive CD4+ T cells can be sensitized with IL-7. Scand J Immunol (2001) 0.80

Poor yield of dendritic cell precursors from untreated pediatric cancer. J Hematother Stem Cell Res (2001) 0.80

Surgical treatment of neuroblastoma: twenty-three years of experience at a single institution. Surg Today (2013) 0.78

Comparative genomic hybridization and conventional cytogenetic analyses in childhood acute myeloid leukemia. Leuk Lymphoma (1999) 0.78

Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL. Pediatr Hematol Oncol (1998) 0.78

Pediatric marrow transplantation for acute leukemia using unrelated donors and T-replete or -depleted grafts: a case-matched analysis. Bone Marrow Transplant (2000) 0.77

Bone marrow remission status predicts leukemia contamination in ovarian biopsies collected for fertility preservation. Leukemia (2012) 0.76

Subnormal androgen levels in young female bone marrow transplant recipients with ovarian dysfunction, chronic GVHD and receiving glucocorticoid therapy. Bone Marrow Transplant (2004) 0.76

Childhood cancer survival in Finland (1953-2010): a nation-wide population-based study. Int J Cancer (2014) 0.76

Very low-dose methotrexate in the treatment of GVHD in children. Bone Marrow Transplant (1997) 0.76

DNA copy number changes in childhood acute lymphoblastic leukemia. Haematologica (1998) 0.76

Comparative genomic hybridization in childhood acute lymphoblastic leukemia. Leukemia (1998) 0.76

Restoration of ovarian function after chemotherapy for osteosarcoma. Arch Dis Child (2003) 0.75

The effects of the mode of delivery on the lymphocyte composition of a placental/cord blood graft. J Hematother (1997) 0.75

Skeletal muscle protein mass correlates with the lipid status in children with solid tumors and before bone marrow transplantation. Eur J Clin Nutr (2000) 0.75

Increase in height during the first year after bone marrow transplantation reflecting nutritional status of children. Bone Marrow Transplant (1998) 0.75

Chediak-Higashi syndrome: four cases from Northern Finland. Acta Paediatr (2003) 0.75

Adrenocortical carcinoma in children: a role for etoposide and cisplatin adjuvant therapy? Preliminary report. Med Pediatr Oncol (2003) 0.75

Loss at 12p detected by comparative genomic hybridization (CGH): association with TEL-AML1 fusion and favorable prognostic features in childhood acute lymphoblastic leukemia (ALL). A multi-institutional study. Med Pediatr Oncol (2001) 0.75

Reemphasis on lymphoblast L2 morphology as a poor prognostic factor in childhood acute lymphoblastic leukemia. Med Pediatr Oncol (1999) 0.75

Impaired androgen production in female adolescents and young adults after total body irradiation prior to BMT in childhood. Bone Marrow Transplant (1997) 0.75

Increased cell turnover, but no signs of increased T-cell infiltration or inflammatory cytokines in the duodenum of pediatric patients after allogeneic stem cell transplantation. Bone Marrow Transplant (2004) 0.75

Follow-up of minimal residual disease in pediatric acute myeloblastic leukemia using metaphase-FISH. Leuk Lymphoma (2002) 0.75

Neutrophil regeneration precedes healing of tissue destruction, as indicated by serum C-reactive protein, in children with cancer recovering from neutropenic fever. Acta Paediatr (2002) 0.75

Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up. Pediatr Hematol Oncol (2001) 0.75

Combined RT-PCR and metaphase-FISH posttransplant studies in pediatric patients with chronic myeloid leukemia. J Pediatr Hematol Oncol (1998) 0.75

Weekend courses for families who have lost a child with cancer. Med Pediatr Oncol (2000) 0.75

Short-term toxicity in pediatric marrow transplantation using related and unrelated donors. Bone Marrow Transplant (1999) 0.75